SR-16435
Cat. No.：YN322351
| 产品名称: | SR-16435 |
| CAS No.: | 1838622-25-5 |
| Chemical Name: | |
| Synonyms: | EST73502;FC1=C(CCN2CCC3(CN(C([C@H](O3)C)=O)CC)CC2)C=C(C=C1)F;(2R)-9-[2-(2,5-Difluorophenyl)ethyl]-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one |
| 分子量: | 352.4188 |
| 分子式: | C19H26F2N2O2 |
| SMILES: | FC1C([H])=C([H])C(=C([H])C=1C([H])([H])C([H])([H])N1C([H])([H])C([H])([H])C2(C([H])([H])N(C([H])([H])C([H])([H])[H])C([C@@]([H])(C([H])([H])[H])O2)=O)C([H])([H])C1([H])[H])F |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | EST73502 是一种选择性的，具有口服活性的，可透过血脑屏障的 μ-opioid 受体 (μ-opioid receptor/MOR) 激动剂和 σ1 受体(σ1R) 拮抗剂，对 MOR 和 σ1R 作用的Ki值分别为 64 nM 和 118 nM。EST73502 可用于缓解疼痛研究。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
